Jaundice in newborns can occur within the first 24 hours of life and is always considered pathological. The causes of jaundice during this period include rhesus and ABO haemolytic diseases, hereditary spherocytosis, and glucose-6-phosphodehydrogenase deficiency. On the other hand, jaundice in neonates from 2-14 days is common and usually physiological, affecting up to 40% of babies. This type of jaundice is due to a combination of factors such as more red blood cells, fragile red blood cells, and less developed liver function. Breastfed babies are more likely to develop this type of jaundice.

If jaundice persists after 14 days (21 days for premature babies), a prolonged jaundice screen is performed. This includes tests for conjugated and unconjugated bilirubin, direct antiglobulin test, thyroid function tests, full blood count and blood film, urine for MC&S and reducing sugars, and urea and electrolytes. Prolonged jaundice can be caused by biliary atresia, hypothyroidism, galactosaemia, urinary tract infection, breast milk jaundice, prematurity, and congenital infections such as CMV and toxoplasmosis. Breast milk jaundice is more common in breastfed babies and is thought to be due to high concentrations of beta-glucuronidase, which increases the intestinal absorption of unconjugated bilirubin. Prematurity also increases the risk of kernicterus.

Molluscum contagiosum is typically observed in children, but the following is a classical depiction of the condition.

Understanding Molluscum Contagiosum

Molluscum contagiosum is a viral skin infection that is commonly seen in children, particularly those with atopic eczema. It is caused by the molluscum contagiosum virus and can be transmitted through direct contact or contaminated surfaces. The infection presents as pinkish or pearly white papules with a central umbilication, which can appear anywhere on the body except for the palms of the hands and soles of the feet. In children, lesions are commonly seen on the trunk and in flexures, while in adults, sexual contact may lead to lesions developing on the genitalia, pubis, thighs, and lower abdomen.

While molluscum contagiosum is a self-limiting condition that usually resolves within 18 months, it is important to avoid sharing towels, clothing, and baths with uninfected individuals to prevent transmission. Scratching the lesions should also be avoided, and treatment may be considered if the itch is problematic. However, treatment is not usually recommended, and if necessary, simple trauma or cryotherapy may be used. In some cases, referral may be necessary, such as for individuals who are HIV-positive with extensive lesions or those with eyelid-margin or ocular lesions and associated red eye.

Overall, understanding molluscum contagiosum and taking appropriate precautions can help prevent transmission and alleviate symptoms.

Common Causes of Ocular Symptoms: A Brief Overview

Giant Cell Arteritis: A large-vessel vasculitis that affects the temporal and ophthalmic arteries, causing headache, scalp tenderness, jaw pain, and visual disturbance. It is more common in females over the age of 70. In clinical practice, temporal artery biopsies performed for evaluation of patients with suspected GCA are positive in 25 to 35 percent of cases. So in this case this is the most likely diagnosis even in the absence of a positive biopsy.

Polyarteritis Nodosa (PAN): A necrotising vasculitis that can affect all age groups, but is more commonly associated with Hepatitis B. Symptoms include myalgia, arthralgia, fever, and weight loss. Ocular involvement is rare.

Diabetic Retinopathy: The most common cause of blindness in adults aged 30-65 in developed countries. Symptoms include microaneurysms, retinal haemorrhages, exudates, cotton wool spots, neovascularisation, and venous changes.

Sjögren Syndrome: An autoimmune disorder characterised by lymphocytic infiltration of salivary and lacrimal glands, resulting in dry eyes and dry mouth.

Central Retinal Vein Occlusion: Can occur in chronic simple glaucoma, arteriosclerosis, hypertension, and polycythaemia. Symptoms include a stormy sunset appearance of the fundus with red haemorrhagic areas and engorged veins.

Women who have recently given birth, whether they are breastfeeding or not, can begin taking the progesterone-only pill at any time postpartum.

It is safe to use progesterone-only pills while breastfeeding, and there is no need to wait for a specific amount of time before starting them. If the pills are started after 21 days, it is recommended to use additional protection for the first 2 days. However, if the woman starts taking the pills immediately, there is no need for extra protection.

Delaying the start of progesterone-only pills can increase the risk of unwanted pregnancy. Therefore, it is important to begin taking them as soon as possible, regardless of whether the woman is breastfeeding or not.

In summary, there is no contraindication to starting progesterone-only pills during the first 21 days postpartum, and breastfeeding does not affect the decision to start them. Women can continue breastfeeding while taking these pills.

After giving birth, women need to use contraception after 21 days. The progestogen-only pill (POP) can be started at any time postpartum, according to the FSRH. Additional contraception should be used for the first two days after day 21. A small amount of progestogen enters breast milk, but it is not harmful to the infant. On the other hand, the combined oral contraceptive pill (COCP) is absolutely contraindicated (UKMEC 4) if breastfeeding is less than six weeks post-partum. If breastfeeding is between six weeks and six months postpartum, it is a UKMEC 2. The COCP may reduce breast milk production in lactating mothers. It should not be used in the first 21 days due to the increased venous thromboembolism risk post-partum. After day 21, additional contraception should be used for the first seven days. The intrauterine device or intrauterine system can be inserted within 48 hours of childbirth or after four weeks.

The lactational amenorrhoea method (LAM) is 98% effective if the woman is fully breastfeeding (no supplementary feeds), amenorrhoeic, and less than six months post-partum. It is important to note that an inter-pregnancy interval of less than 12 months between childbirth and conceiving again is associated with an increased risk of preterm birth, low birth weight, and small for gestational age babies.

Understanding Schizoid Personality Disorder: Differentiating from Other Psychiatric Conditions

Personality disorders are characterized by enduring patterns of perception, processing, and engagement that become ingrained, inflexible, and maladaptive. Schizoid personality disorder is a type of personality disorder that falls under the weird cluster of disorders. Patients with this disorder are withdrawn loners with flat affects, but they do not have weird/magical thinking (schizotypal) or psychotic symptoms (schizophrenia, schizoaffective disorder). They classically have a very flat affect and no interest in interpersonal relationships, preferring to work and play alone. It is important to differentiate schizoid personality disorder from other psychiatric conditions such as schizophrenia, avoidant personality disorder, schizoaffective disorder, and schizotypal personality disorder, as they have distinct features and treatment approaches.

Palmoplantar pustulosis is often accompanied by psoriasis on other areas of the body and is strongly linked to smoking. Unlike pompholyx eczema, the connection to high temperatures and humidity is not as significant. Scabies, which is caused by the parasite Sarcoptes scabiei, results in severe itching of the hands and web spaces but is typically not a recurring issue. Symptoms include linear burrows and erythematous papules rather than vesicles.

Understanding Pompholyx Eczema

Pompholyx eczema, also known as dyshidrotic eczema, is a type of skin condition that affects both the hands and feet. It is often triggered by high temperatures and humidity, such as sweating. The main symptom of pompholyx eczema is the appearance of small blisters on the palms and soles, which can be intensely itchy and sometimes accompanied by a burning sensation. Once the blisters burst, the skin may become dry and crack.

To manage pompholyx eczema, cool compresses and emollients can be used to soothe the affected areas. Topical steroids may also be prescribed to reduce inflammation and itching. It is important to avoid further irritation by wearing gloves or protective footwear and avoiding exposure to irritants. With proper management, the symptoms of pompholyx eczema can be controlled and minimized.

The symptoms of keratoconjunctivitis sicca include a sensation of dryness, burning, and grittiness in the eyes, which is caused by a reduction in the production of tears.

Rheumatoid Arthritis and Its Effects on the Eyes

Rheumatoid arthritis is a chronic autoimmune disease that affects various parts of the body, including the eyes. In fact, ocular manifestations of rheumatoid arthritis are quite common, with approximately 25% of patients experiencing eye problems. These eye problems can range from mild to severe and can significantly impact a patient’s quality of life.

The most common ocular manifestation of rheumatoid arthritis is keratoconjunctivitis sicca, also known as dry eye syndrome. This condition occurs when the eyes do not produce enough tears, leading to discomfort, redness, and irritation. Other ocular manifestations of rheumatoid arthritis include episcleritis, scleritis, corneal ulceration, and keratitis. Episcleritis and scleritis both cause redness in the eyes, with scleritis also causing pain. Corneal ulceration and keratitis both affect the cornea, with corneal ulceration being a more severe condition that can lead to vision loss.

In addition to these conditions, patients with rheumatoid arthritis may also experience iatrogenic ocular manifestations. These are side effects of medications used to treat the disease. For example, steroid use can lead to cataracts, while the use of chloroquine can cause retinopathy.

Overall, it is important for patients with rheumatoid arthritis to be aware of the potential ocular manifestations of the disease and to seek prompt medical attention if they experience any eye-related symptoms. Early diagnosis and treatment can help prevent vision loss and improve overall quality of life.

Cystic fibrosis is a genetic disorder that affects the lungs and is inherited in an autosomal recessive manner. In the United Kingdom, newborns are screened for cystic fibrosis on the sixth day of life using a dried blood spot collected on a Guthrie card.

Understanding Cystic Fibrosis and the Organisms that Affect Patients

Cystic fibrosis is a genetic disorder that causes thickened secretions in the lungs and pancreas. This condition is caused by a defect in the cystic fibrosis transmembrane conductance regulator gene (CFTR), which regulates chloride channels. In the UK, 80% of CF cases are due to delta F508 on chromosome 7, and the carrier rate is approximately 1 in 25.

CF patients are susceptible to colonization by certain organisms, including Staphylococcus aureus, Pseudomonas aeruginosa, Burkholderia cepacia, and Aspergillus. These organisms can cause infections and exacerbate symptoms in CF patients. It is important for healthcare providers to monitor and manage these infections to improve patient outcomes. By understanding the genetic basis of CF and the organisms that affect patients, healthcare providers can provide better care for those with this condition.

If a beta-blocker is not effective in controlling angina, it is recommended to add a longer-acting dihydropyridine calcium channel blocker such as amlodipine. Diltiazem and verapamil should not be used in combination with a beta-blocker due to the risk of life-threatening bradycardia and heart failure. Ivabradine and nicorandil can be used as alternatives if a dihydropyridine CCB is not suitable, but should only be initiated under specialist advice.

Angina pectoris is a condition that can be managed through various methods, including lifestyle changes, medication, percutaneous coronary intervention, and surgery. In 2011, NICE released guidelines for the management of stable angina. Medication is an important aspect of treatment, and all patients should receive aspirin and a statin unless there are contraindications. Sublingual glyceryl trinitrate can be used to abort angina attacks. The first-line medication should be either a beta-blocker or a calcium channel blocker, depending on the patient’s comorbidities, contraindications, and preferences. If a calcium channel blocker is used as monotherapy, a rate-limiting one such as verapamil or diltiazem should be used. If used in combination with a beta-blocker, a longer-acting dihydropyridine calcium channel blocker should be used. Beta-blockers should not be prescribed concurrently with verapamil due to the risk of complete heart block. If the initial treatment is not effective, medication should be increased to the maximum tolerated dose. If a patient is still symptomatic after monotherapy with a beta-blocker, a calcium channel blocker can be added, and vice versa. If a patient cannot tolerate the addition of a calcium channel blocker or a beta-blocker, other drugs such as long-acting nitrates, ivabradine, nicorandil, or ranolazine can be considered. Nitrate tolerance is a common issue, and patients who take standard-release isosorbide mononitrate should use an asymmetric dosing interval to maintain a daily nitrate-free time of 10-14 hours to minimize the development of nitrate tolerance. This effect is not seen in patients who take once-daily modified-release isosorbide mononitrate. If a patient is taking both a beta-blocker and a calcium-channel blocker, a third drug should only be added while awaiting assessment for PCI or CABG.

Management of Phaeochromocytoma: Medications and Interventions

Phaeochromocytoma is a neuroendocrine tumor that secretes adrenaline and noradrenaline, leading to sympathetic stimulation and clinical symptoms such as tachycardia, hypertension, anxiety, diaphoresis, and weight loss. Diagnosis is made through the measurement of catecholamines and metanephrines in plasma or urine. Surgery is required, but patients are at high risk due to potential life-threatening tachycardia and hypertension. The following medications and interventions are used in the management of phaeochromocytoma:

Alpha-adrenergic receptor blockers: Phenoxybenzamine or doxazosin are used to dampen sympathetic stimulation by blocking alpha-adrenoceptors.

Beta-adrenergic receptor blockers: Beta-blockers are used after alpha-blockers to avoid unopposed alpha-receptor stimulation, which can cause a hypertensive crisis.

Calcium channel blockers: These are not commonly used in phaeochromocytoma management but may be used as an antihypertensive in certain populations or as an anti-anginal drug.

Intravenous fluids: IV fluids should be readily available for all surgeries to address potential blood loss and hypotension following surgery.

Low-salt diet and low fluid intake: These interventions are not typically used in phaeochromocytoma management but may be used for chronic hypertension or fluid overload.